CNCR
$9.02
Range Cancer Therapeutics ETF
Fund Family: ETF Series Solutions
Top 10 Holdings
Largest positions representing 26.9% of the portfolio
26.9%
of portfolio
Loading chart...
| Rank | Company | Ticker | Sector | Weight (%) |
|---|---|---|---|---|
1 | Recursion Pharmaceuticals Inc 75629V104 | RXRX | Professional, Scientific, and Technical Services | 4.01% |
2 | Precigen Inc 74017N105 | PGEN | Professional, Scientific, and Technical Services | 3.05% |
3 | Compass Therapeutics Inc 20454B104 | CMPX | Professional, Scientific, and Technical Services | 2.99% |
4 | Genelux Corp 36870H103 | GNLX | Unknown | 2.90% |
5 | SpringWorks Therapeutics Inc 85205L107 | 85205L107 | Unknown | 2.86% |
6 | Exelixis, Inc. 30161Q104 | EX9 | Unknown | 2.48% |
7 | Ginkgo Bioworks Holdings Inc 37611X209 | DNA | Manufacturing | 2.33% |
8 | Replimune Group Inc 76029N106 | REPL | Professional, Scientific, and Technical Services | 2.14% |
9 | Bristol-Myers Squibb Co 110122108 | BMY | Manufacturing | 2.10% |
10 | Schrodinger Inc/United States 80810D103 | SDGR | Manufacturing | 1.98% |